Chilton Investment Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Buy
+8,662
New +$231K 0.01% 267
2025
Q4
Sell
-7,892
Closed -$201K 296
2025
Q3
$201K Buy
+7,892
New +$195K ﹤0.01% 271
2021
Q2
Sell
-5,862
Closed -$212K 148
2021
Q1
$212K Sell
5,862
-810
-12% -$28.8K 0.01% 147
2020
Q4
$246K Sell
6,672
-408
-6% -$15K 0.01% 134
2020
Q3
$247K Sell
7,080
-432
-6% -$15.1K 0.01% 136
2020
Q2
$233K Buy
7,512
+385
+5% +$13.1K 0.01% 136
2020
Q1
$221K Sell
7,127
-4,099
-37% -$140K 0.01% 106
2019
Q4
$417K Buy
11,226
+3,743
+50% +$133K 0.01% 109
2019
Q3
$255K Sell
7,483
-616
-8% -$22.4K 0.01% 117
2019
Q2
$333K Sell
8,099
-580
-7% -$23K 0.01% 97
2019
Q1
$350K Hold
8,679
0.01% 104
2018
Q4
$359K Buy
+8,679
New +$360K 0.01% 112
2017
Q4
Sell
-6,611
Closed -$224K 130
2017
Q3
$224K Sell
6,611
-398
-6% -$12.8K 0.01% 126
2017
Q2
$223K Sell
7,009
-129
-2% -$4.07K 0.01% 130
2017
Q1
$232K Buy
7,138
+264
+4% +$8.32K 0.01% 128
2016
Q4
$212K Buy
6,874
+232
+3% +$7.08K 0.01% 124
2016
Q3
$213K Buy
+6,642
New +$222K 0.01% 116
2016
Q2
Sell
-31,157
Closed -$876K 127
2016
Q1
$876K Sell
31,157
-18,045
-37% -$515K 0.03% 90
2015
Q4
$1.51M Buy
49,202
+30,001
+156% +$944K 0.05% 85
2015
Q3
$572K Hold
19,201
0.02% 128
2015
Q2
$611K Buy
+19,201
New +$626K 0.02% 124

Other funds holding PFE

Chilton Investment Company's PFE Position: Q1 2026 in Review

Chilton Investment Company opened a new position in Pfizer (PFE) in Q1 2026: 8,662 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #267 among its holdings. This is a return to the name: Chilton Investment Company previously reported a position in PFE as recently as Q3 2025.

Chilton Investment Company first reported a position in PFE in Q2 2015 and has held it in 21 quarters since. The position peaked at $1.51M in Q4 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Chilton Investment Company held 8,662 shares of Pfizer worth $243K as of Q1 2026.
  • Pfizer was a new Chilton Investment Company position in Q1 2026.
  • Pfizer made up 0.01% of Chilton Investment Company's portfolio in Q1 2026, its #267 holding.
  • Chilton Investment Company first reported a position in Pfizer in Q2 2015 and has held it in 21 quarters since.
  • Chilton Investment Company's Pfizer position peaked at $1.51M in Q4 2015.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.